Research outputs
2025
Prospective neuroimaging and neuropsychological evaluation in adults with newly diagnosed focal epilepsy
de Bezenac, C. E., Leek, N., Adan, G., Ali, A. M. S., Mohanraj, R., Biswas, S., . . . Keller, S. S. (2025). Prospective neuroimaging and neuropsychological evaluation in adults with newly diagnosed focal epilepsy. Epilepsia, 66(8), 2864-2880. doi:10.1111/epi.18410
2024
Prospective neuroimaging and neuropsychological evaluation in adults with newly diagnosed focal epilepsy
2020
Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apnea–hypnoea index (AHI)
Sprung, V. S., Kemp, G. J., Wilding, J. P. H., Adams, V., Murphy, K., Burgess, M., . . . Cuthbertson, D. J. (2020). Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apnea–hypnoea index (AHI). BMJ Open, 10(7), e038856. doi:10.1136/bmjopen-2020-038856